<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="lose">
            <roleset id="lose.01" name="" wordnet="1, 8">
                <roles>
                    <role n="0" descr="entity losing something&#x0A;" />
                    <role n="1" descr="thing lost&#x0A;" />
                    <role n="2" descr="situation inducing thing lost&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A0 (The hnRNP A1 C-terminal-deletion mutant is able to lose A1 (the ability to interact with the X protein and attract it to the initiation complex) results in and inhibits MHV transcription and replication.</text>
                </example>
                <example src="EGRAM" no="1">
                    <text>A0 (hnRNP A1 C-terminal mutant that loses A1 (the ability to interact with the X protein and transport it to the initiation complex) results in inhibition of RNA transcription and replication MHV.</text>
                </example>
                <example src="EGRAM" no="2">
                    <text>A0 (hnRNP A1 C-terminal mutant that losing A1 (the ability to interact with the X protein and transport it to the initiation complex) results in inhibition of RNA transcription and replication MHV.</text>
                </example>
                <example src="EGRAM" no="3">
                    <text>A0 (the C-terminal mutation of hnRNP A1 lost A1 (the ability to interact with the X protein and transport it to the initiation complex), resulting in inhibition of the transcription and replication of MHV RNA.</text>
                </example>
                <example src="EGRAM" no="4">
                    <text>A0 has been characterized (a new variant of transtiretin) that has lost a site of Sph I segmentation within exon 3.</text>
                    <arg n="1">a site of Sph I segmentation within exon 3</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>A0 has been characterized (a new variant of transtiretin) that loses a place of Sph I segmentation within exon 3.</text>
                    <arg n="1">a place of Sph I segmentation within exon 3</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>A0 is capable of completely losing its prokaryoto-like genome, but all exhibit considerable genome reduction and core dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="1">its prokaryoto-like genome</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>A0 was characterized (a new variant of transtiretin) that lost a Sph I segmentation site within exon 3.</text>
                    <arg n="1">a Sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>All Purkinje cells a1 have a high probability of being lost postnatally to accessing chimes between Lc/+ mice.</text>
                    <arg n="0">accessing chimes between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>All Purkinje cells can be lost postnatally to aggregational tissues between Lc/+ mice.</text>
                    <arg n="0">aggregational tissues between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>All cells of P. aureus A1 will be lost in the postnatal period by aggregational liquids between Lc/+ mice.</text>
                    <arg n="0">aggregational liquids between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>All cells of P. aureus A1 will probably be lost in the postnatal period to probably aggregation groups between Lc/+ mice.</text>
                    <arg n="0">probably aggregation groups between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>All cells of P. aureus A1 would probably be lost in the postnatal period by aggregation polymer between Lc/+ mice.</text>
                    <arg n="0">aggregation polymer between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>All cells of P. aureus are lost in the postnatal period by aggregation polymer between Lc/+ mice.</text>
                    <arg n="0">aggregation polymer between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>All cells of P. aureus can be lost in the postnatal period by aggregational pathways between Lc/+ mice.</text>
                    <arg n="0">aggregational pathways between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>All cells of P. aureus can be lost in the postnatal period by assembly groups between Lc/+ mice.</text>
                    <arg n="0">assembly groups between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>All cells of P. aureus were lost in the postnatal period by aggregation polymer between Lc/+ mice.</text>
                    <arg n="0">aggregation polymer between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>C-terminal-deletion mutant of hnRNP A1 is observed to lose A1 (the ability to interact with protein X and to introduce it into the initiation complex), resulting in inhibition of RNA transcription and replication MHV.</text>
                    <arg n="0">C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>For this purpose, A0 was made (aggregation chimes between Lc/+ mice), which have a high probability of losing all P. cruzi cells in the postnatal period, and control +/+.</text>
                </example>
                <example src="EGRAM" no="19">
                    <text>For this purpose, A0 was made (aggregation polymers between Lc/+ mice), which could lose all P. cruzi cells in the postnatal period, and control of +/+ mice.</text>
                </example>
                <example src="EGRAM" no="20">
                    <text>For this purpose, A0 was made (aggregation polymers between Lc/+ mice), which would probably lose all cells of P. cruzi in the postnatal period, and control of +/+ mice.</text>
                </example>
                <example src="EGRAM" no="21">
                    <text>For this purpose, A0 was made (chimeras of aggregation between Lc/+ mice), which probably lose all P. cruzi cells in the postnatal period, and the control +/+ mice.</text>
                </example>
                <example src="EGRAM" no="22">
                    <text>For this purpose, A0 was made (chimeras of aggregation between Lc/+ mice), which would probably lose all P. cruzi cells in the postnatal period, and the control +/+ mice.</text>
                </example>
                <example src="EGRAM" no="23">
                    <text>For this purpose, a0 (aggregational circles between Lc/+ mice) was performed, which are observed to lose all A1 cells (purkinje) in the postnatal period, and to control +/+ mice.</text>
                </example>
                <example src="EGRAM" no="24">
                    <text>For this purpose, accessive aggregation chimes between Lc/+ mice were made, which may lose all P. cruzi cells in the postnatal period, and control of +/+ mice.</text>
                    <arg n="0">accessive aggregation chimes between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>For this purpose, aggregation burn between Lc/+ mice was able to losing all A1 cells (purkinje) in the postnatal period, and the control +/+ mice.</text>
                    <arg n="0">aggregation burn between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>For this purpose, aggregation chimes between Lc/+ mice were made, which will lose all P. cruzi cells in the postnatal period, and control of +/+ mice.</text>
                    <arg n="0">aggregation chimes between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>For this purpose, chimeras of aggregation between Lc/+ mice was made, which have the ability to lose all P. cruzi cells in the postnatal period, and the control +/+ mice.</text>
                    <arg n="0">chimeras of aggregation between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>For this purpose, chimeras of aggregation between Lc/+ mice was made, which lost all P. cruzi cells in the postnatal period, and the control +/+ mice.</text>
                    <arg n="0">chimeras of aggregation between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>For this purpose, it was made aggregation chimes between Lc/+ mice, which lost all P. cruzi cells in the postnatal period, and control of +/+ mice.</text>
                    <arg n="0">aggregation chimes between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>For this purpose, it was made aggregation polymers between Lc/+ mice, which would probably lose all cells of P. cruzi in the postnatal period, and control +/+.</text>
                    <arg n="0">aggregation polymers between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>For this purpose, the a0 (access to kimes) was made among Lc/+ mice, which would lose all A1 cells (purkinje) in the postnatal period, and control +/+ mice.</text>
                </example>
                <example src="EGRAM" no="32">
                    <text>For this purpose, they made aggregation chimes between Lc/+ mice, which are able to lose all P. cruzi cells in the postnatal period, and control of +/+ mice.</text>
                    <arg n="0">aggregation chimes between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>For this purpose, we performed a0 (access to chimes among Lc/+ mice), which will probably lose all A1 cells (purkinje) in the postnatal period, and the control +/+ mice.</text>
                </example>
                <example src="EGRAM" no="34">
                    <text>For this purpose, we performed a0 (access to chimes among Lc/+ mice), which would probably lose all A1 cells (purkinje) in the postnatal period, and the control +/+ mice.</text>
                </example>
                <example src="EGRAM" no="35">
                    <text>IGPI anchoring capacity lost when the microsomal membranes of Trypanosoma brucei were washed at high pH was reported (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals had no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>IGPI anchoring capacity lost when the microsomal membranes of Trypanosoma brucei were washed at high pH was reported (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>IGPI anchoring capacity was reported as lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>IIGPI anchoring capacity is lost to when the microsomal membranes of Trypanosoma brucei were washed at a high pH (Sharma et al., 2000), while the similar treatment of mammalian microsomal membranes has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>IIGPI anchoring capacity lost when the microsomal membranes of Trypanosoma brucei were washed at a high pH was reported (Sharma et al., 2000), while the similar treatment of mammalian microsomal membranes had no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>IIGPI anchoring capacity lost when the microsomal membranes of Trypanosoma brucei were washed at a high pH was reported (Sharma et al., 2000), while the similar treatment of mammalian microsomal membranes has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>IIGPI anchoring capacity was reported as lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while the similar treatment of the microsomal membranes of mammals has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>It can be reported that IGPI anchoring capacity will be lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals had no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>It has been characterized that a new variant of transtiretin is capable of losing a place of segmentation Sph I within exon 3.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a place of segmentation Sph I within exon 3</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>It has been observed that no prokaryotic organelle genome is completely lost in any known plastid, but they all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plastid</arg>
                    <arg n="1">no prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>It has been reported that IGPI anchoring capacity could be lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>It has been reported that IGPI anchoring capacity is lost when the microsome membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the mammalian microsome membranes has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsome membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>It has been reported that IGPI anchoring capacity may be lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>It has been reported that IGPI anchoring capacity was able to be lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>It has been reported that IGPI anchoring capacity was lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals had no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>It has been reported that IGPI anchoring capacity was lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>It has been reported that IGPI anchoring capacity would be lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), while similar treatment of the microsomal membranes of mammals has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>It has been reported that IIGPI anchoring capacity can be lost when the microsomal membranes of Trypanosoma brucei were washed at a high pH (Sharma et al., 2000), while the similar treatment of mammalian microsomal membranes has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>It has been reported that IIGPI anchoring capacity could be lost to when the microsomal membranes of Trypanosoma brucei were washed at a high pH (Sharma et al., 2000), while similar treatment of mammalian microsomal membranes has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>It has been reported that IIGPI anchoring capacity was able to lost when the microsomal membranes of Trypanosoma brucei were washed at a high pH (Sharma et al., 2000), while the similar treatment of mammalian microsomal membranes has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>It has been reported that IIGPI anchoring capacity was lost when the microsomal membranes of Trypanosoma brucei were washed at a high pH (Sharma et al., 2000), while the similar treatment of mammalian microsomal membranes had no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>It has been reported that IIGPI anchoring capacity was lost when the microsomal membranes of Trypanosoma brucei were washed at a high pH (Sharma et al., 2000), while the similar treatment of mammalian microsomal membranes has no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IIGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>It is observed that all A1 cells (purkinje cells) are lost in the postnatal period to aggregation burns between Lc/+ mice.</text>
                    <arg n="0">aggregation burns between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>It is observed that no genome of prokaryotic organelles is completely lost in any known plaside, but all have a considerable reduction in genome and nucleus dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plaside</arg>
                    <arg n="1">no genome of prokaryotic organelles</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>It is observed that no plastid is known completely loses its prokaryotic organelle genome, but they all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>It is observed that no prokaryotic organelle genome is completely lost in any known plastid, but they all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plastid</arg>
                    <arg n="1">no prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>It is observed that the hnRNP A1 mutation C-terminal-deletion loses A1 (the ability to interact with the X protein and carry it to the initiation complex), resulting in transcription inhibition and replication of MHV RNA.</text>
                    <arg n="0">the hnRNP A1 mutation C-terminal-deletion</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>It is observed that these interactions lost with a separation of the DNA binding sites of }3 bp, as can occur in natural SRE sequences, while smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the DNA binding sites of }3 bp</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>It is reported that IGPI anchoring capacity will lost when the microsomal membranes of Trypanosoma brucei were washed at a high pH (Sharma et al., 2000), while similar treatment of mammalian microsomal membranes had no effect (Vidugiriene and Menon, 1995).</text>
                    <arg n="1">IGPI anchoring capacity</arg>
                    <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at a high pH</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>It was reported that GPI anchoring ability would be lost to when the brucei microsoma membranes were washed at high pH (Sharma et al., 2000), while similar treatment of mammalian microsomaly membranes have no effect (Vidugiriene and Menon, 1995)</text>
                    <arg n="1">GPI anchoring ability</arg>
                    <arg n="2">when the brucei microsoma membranes were washed at high pH</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>M mice are non- able to lose weight during treatment.</text>
                    <arg n="0">M</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">non-</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>M mice have not lost weight during treatment.</text>
                    <arg n="0">M mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>M mice lose no {\displaystyle weight during treatment.</text>
                    <arg n="0">M mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">no</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>M mice lost loss of no weight during treatment.</text>
                    <arg n="0">M mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">no</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>M-NEG mice (no) have the ability to lose weight during treatment.</text>
                    <arg n="0">M-NEG mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>M-NEG mice (not) is very likely to losing weight during treatment.</text>
                    <arg n="0">M-NEG mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>Mice are non- able to lose weight during treatment.</text>
                    <arg n="0">Mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">non-</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>Mice lose no loss A1 (weight) A2 (during treatment) (no loss weight during treatment.</text>
                    <arg n="0">Mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">no loss A1 (weight) A2 (during treatment)</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>Mice may have lost weight during treatment.</text>
                    <arg n="0">Mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>Mice may lose M-NG (no) weight during treatment.</text>
                    <arg n="0">Mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>Mice may lose weight during treatment.</text>
                    <arg n="0">Mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>Mice will lose no weight during treatment.</text>
                    <arg n="0">Mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">no</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>No known plastic species is completely losing the its prokaryotic organelle genome, but all exhibit considerable reduction and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No known plastic species</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>No plastic species are known completely loses its prokaryoto-type genome, but they all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastidi functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No plastic species are known</arg>
                    <arg n="1">its prokaryoto-type genome</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>No plastic species is known completely loses its prokaryotic organelle genome, but all exhibit considerable reduction and dependence on the nucleus to fulfill the plastic functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No plastic species is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>No plastic species is known completely lost its prokaryotic organelle genome, but all show a considerable reduction and dependence on the nucleus to fulfill the plastic functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No plastic species is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>No plastid is known can completely lost its prokaryotic organelle genome, but they all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>No plastid is known completely loses its prokaryotic organelle genome, but they all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>No plastid is known completely lost its prokaryotic organelle genome, but all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>No plastid is known has the ability to completely lose its prokaryotic organelle genome, but they all show a considerable reduction in the genome and the dependence of the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>No plastid is known is completely losing its prokaryotic organelle genome, but they all losing a considerable reduction in the genome and the dependence of the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">No plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>No serious complications have been reported and after IBB removal, subjects are maintaining the results obtained, but some of them are able to lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>No serious complications have been reported and after IBB removal, subjects are maintaining the results obtained, but some of them has a high probability of losing weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>No serious complications have been reported and after IBI extraction subjects maintain the results obtained, but some of them is likely to lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>No serious complications have been reported and after IBI removal, subjects are maintaining the results obtained, but some of them may lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>No serious complications have been reported and after IBI removal, subjects are maintaining the results obtained, but some of them may probably lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="91">
                    <text>No serious complications have been reported and after IBI removal, subjects are maintaining the results obtained, but some of them will lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="92">
                    <text>No serious complications have been reported and after IBI removal, subjects are maintaining the results obtained, but some of them will probably lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="93">
                    <text>No serious complications have been reported and after the removal of the IBB, subjects maintain the results obtained, but some of them are able to lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="94">
                    <text>No serious complications have been reported and after the removal of the IBB, subjects maintain the results obtained, but some of them has a high probability of losing weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="95">
                    <text>No serious complications have been reported and after the removal of the IBB, subjects maintain the results obtained, but some of them seems to lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="96">
                    <text>No serious complications have been reported and after the removal of the IBI, subjects maintain the results obtained with some of them while losing weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="97">
                    <text>No serious complications have been reported and after the removal of the IBI, subjects maintain the results obtained, but some of them loses weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="98">
                    <text>No serious complications have been reported and after the removal of the IBI, subjects maintain the results obtained, but some of them may have lost weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="99">
                    <text>No serious complications have been reported and after the removal of the IBI, subjects maintain the results obtained, but some of them may lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="100">
                    <text>No serious complications have been reported and after the removal of the IBI, subjects maintain the results obtained, but some of them probably loses weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="101">
                    <text>No serious complications have been reported and after the removal of the IBI, subjects maintain the results obtained, but some of them will lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="102">
                    <text>No serious complications have been reported and after the removal of the IBI, subjects maintain the results obtained, but some of them will probably lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="103">
                    <text>No serious complications have been reported, and after extracting BIB, subjects are keeping the results obtained, but some of them seem to lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="104">
                    <text>No serious complications have been reported, and after extracting BIB, subjects keep the results obtained, but some of them lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="105">
                    <text>No serious complications have been reported, and after extracting BIB, subjects maintain the results obtained, but some of them have lost weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="106">
                    <text>No serious complications have been reported, and after the extraction of BIB, subjects keep the results obtained, but some of them may have lost weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="107">
                    <text>No serious complications have been reported, and after the extraction of BIB, subjects maintain the results obtained with some of them continue to losing weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="108">
                    <text>No serious complications have been reported, and after the extraction of BIB, subjects maintain the results obtained, but it has been observed that some of them loses weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="109">
                    <text>No serious complications have been reported, and after the extraction of BIB, subjects maintain the results obtained, but it is observed that some of them loses weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="110">
                    <text>No serious complications have been reported, and after the extraction of BIB, subjects maintain the results obtained, but some of them is likely to lose weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="111">
                    <text>No serious complications have been reported, and after the extraction of BIB, subjects maintain the results obtained, but some of them lost weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="112">
                    <text>No serious complications were reported and after IBB extraction, the subjects maintained the results obtained, but it has been observed that some of them loses weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="113">
                    <text>No serious complications were reported and after the removal of the IBB, subjects maintain the results, but some of them loses weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="114">
                    <text>No serious complications were reported, and after the removal of the IBB, subjects retained the results, but some of them lost weight.</text>
                    <arg n="0">some of them</arg>
                    <arg n="1">weight</arg>
                </example>
                <example src="EGRAM" no="115">
                    <text>Previous studies emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that lost the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="116">
                    <text>Previous studies emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that would lose the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="117">
                    <text>Previous studies emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, leading grasslands to lose the first 20 70 residues, but maintaining the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">grasslands</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="118">
                    <text>Previous studies emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, resulting in romited species losing the first 20 70 residues, but maintaining the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">romited species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="119">
                    <text>Previous studies emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, resulting in romited species lost the first 20 70 residues, but maintaining the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">romited species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="120">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that has the ability to lose the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="121">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that is able to lose the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="122">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that loses the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="123">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that may lose the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="124">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that may probably lose the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="125">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that probably loses the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="126">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that will lose the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="127">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that will probably lose the first 20 70 residues, but that retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="128">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species which has a high probability of losing the first 20 70 residues, but which retain enzymatic activity and dimeric structure.</text>
                    <arg n="0">truncated species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="129">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, leading A0 to losing the first 20 70 residues but to maintain enzyme activity and dimer structure.</text>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="130">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, leading A0 to losing the first 20 70 residues but to maintain the enzymatic activity and the structure of the dimers.</text>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="131">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, leading to grasslands that will probably lose the first 20 70 residues, but retain the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">grasslands</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="132">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, resulting in breaked species having a high probability of losing the first 20 70 residues, but maintaining the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">breaked species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="133">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, resulting in romited species that may lose the first 20 70 residues but maintain the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">romited species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="134">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, resulting in romited species that probably lose the first 20 70 residues, but retain the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">romited species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="135">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, resulting in ruped species being able to lose the first 20 70 residues, but maintaining the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">ruped species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="136">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, resulting in ruped species having the ability to lose the first 20 70 residues, but maintaining the enzymatic activity and the structure of the dimers.</text>
                    <arg n="0">ruped species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="137">
                    <text>Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic segmentation, resulting in ruptured species being observed to lose the first 20 70 residues but maintaining enzyme activity and dimer structure.</text>
                    <arg n="0">ruptured species</arg>
                    <arg n="1">the first 20 70 residues</arg>
                </example>
                <example src="EGRAM" no="138">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, along other stages, in acute T-cell leukaemia cells that are able to lose IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukaemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="139">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, along other stages, in acute T-cell leukaemia cells that are observed to lose IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukaemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="140">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, along other stages, in acute T-cell leukaemia cells that lose IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukaemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="141">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, along other stages, in acute T-cell leukaemia cells that may lose IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukaemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="142">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, along other stages, in acute T-cell leukaemia cells which will lose dependence IL-2 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukaemia cells</arg>
                    <arg n="1">dependence IL-2</arg>
                </example>
                <example src="EGRAM" no="143">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, along other stages, in acute T-cell leukaemia cells which will probably lose IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukaemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="144">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, over other stages, in acute T leukemia cells that are able to lose IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T leukemia cells</arg>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="145">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, over other stages, in acute T leukemia cells that are observed to lose IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T leukemia cells</arg>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="146">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, over other stages, in acute T leukemia cells that have the ability to lose IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T leukemia cells</arg>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="147">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, over other stages, in acute T leukemia cells that may lose IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T leukemia cells</arg>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="148">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, over other stages, in acute T leukemia cells which have a high probability of losing IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T leukemia cells</arg>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="149">
                    <text>Stat3 is activated in transformed cells v-Src or v-abl and, over other stages, in acute T-cell leukemia cells, which will probably lose IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="150">
                    <text>Stat3 is activated in v-Src or v-abl transform cells and, along other stages, in acute T cell leukemia cells losing IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="151">
                    <text>Stat3 is activated in v-Src or v-abl transform cells and, along other stages, in acute T-cell leukaemia cells that have a high probability of losing IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukaemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="152">
                    <text>Stat3 is activated in v-Src or v-abl transform cells and, along other stages, in acute T-cell leukaemia cells that have the ability to lose IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukaemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="153">
                    <text>Stat3 is activated in v-Src or v-abl transform cells and, along other stages, in acute T-cell leukemia cells that lost IL-2 dependency (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukemia cells</arg>
                    <arg n="1">IL-2 dependency</arg>
                </example>
                <example src="EGRAM" no="154">
                    <text>State3 is activated in cells transformed by v-Src or v-abl and, along other stages, in T-Leukemia cells that have lost IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">T-Leukemia cells</arg>
                    <arg n="1">IL-2</arg>
                </example>
                <example src="EGRAM" no="155">
                    <text>State3 is activated in cells transformed by v-Src or v-abl and, along other stages, in acute T cell leukaemia balloon losing IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T cell leukaemia balloon</arg>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="156">
                    <text>State3 is activated in cells transformed by v-Src or v-abl and, along other stages, in acute T-cell leukemia that lose IL-2 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukemia</arg>
                    <arg n="1">IL-2</arg>
                </example>
                <example src="EGRAM" no="157">
                    <text>State3 is activated in cells transformed by v-Src or v-abl and, along other stages, in acute T-cell leukemia that may lose IL-2 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukemia</arg>
                    <arg n="1">IL-2</arg>
                </example>
                <example src="EGRAM" no="158">
                    <text>State3 is activated in cells transformed by v-Src or v-abl and, along other stages, in acute T-cell leukemias which will lose IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="0">acute T-cell leukemias</arg>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="159">
                    <text>State3 is activated in transformed cells v-Src or v-abl and, over other stages, in acute T-cell leukemia cells that may lose IL-2 dependence (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="1">IL-2 dependence</arg>
                </example>
                <example src="EGRAM" no="160">
                    <text>State3 is activated in v-Src or v-abl transform cells and, along other stages, in acute T-cell leukaemia cells that may lose dependence IL-2 (Migone et al., 1995; Yu et al., 1995).</text>
                    <arg n="1">dependence IL-2</arg>
                </example>
                <example src="EGRAM" no="161">
                    <text>The C-terminal deletion mutant of hnRNP A1 may lose A1 (the ability to interact with the X protein and to introduce it into the initiation complex), resulting in inhibition of RNA transcription and replication MHV.</text>
                    <arg n="0">The C-terminal deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="162">
                    <text>The C-terminal deletion mutant of hnRNP A1 will lose A1 (the ability to interact with the X protein and to introduce it into the initiation complex), resulting in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="163">
                    <text>The C-terminal mutant of hnRNP A1 has been losing A1 (the ability to interact with the X protein and to introduce it into the initiation complex), resulting in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="164">
                    <text>The C-terminal mutant of hnRNP A1 may have lost A1 (the ability to interact with the X protein and to introduce it into the initiation complex), resulting in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="165">
                    <text>The C-terminal mutant of hnRNP A1 may probably lose A1 (the ability to interact with the X protein and to introduce it into the initiation complex), resulting in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="166">
                    <text>The C-terminal mutant of hnRNP A1 that may probably lose A1 (the ability to interact with the X protein and to introduce it into the initiation complex) results in and inhibits the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="167">
                    <text>The C-terminal mutant of hnRNP A1 will probably lose A1 (the ability to interact with the X protein and to introduce it into the initiation complex), resulting in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="168">
                    <text>The C-terminal-deletion mutant of hnRNP A1 has the ability to lose A1 (the ability to interact with the X protein and to lead it to the initiation complex), resulting in an inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="169">
                    <text>The C-terminal-deletion mutant of hnRNP A1 is able to lose A1 (the ability to interact with the X protein and attract it to the initiation complex) results in and inhibits the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="170">
                    <text>The C-terminal-deletion mutant of hnRNP A1 is highly likely to losing A1 (the ability to interact with the X protein and to lead it to the initiation complex), resulting in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="171">
                    <text>The C-terminal-deletion mutant of hnRNP A1 lost A1 (the ability to interact with the X protein and attract it to the initiation complex), resulting in an inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="172">
                    <text>The C-terminal-deletion mutant of hnRNP A1 lost A1 (the ability to interact with the X protein and to lead it to the initiation complex), resulting in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="173">
                    <text>The C-terminal-deletion mutant of hnRNP A1 that loses A1 (the ability to interact with the X protein and attract it to the initiation complex) results in and inhibits the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="174">
                    <text>The C-terminal-deletion mutant of hnRNP A1 that lost A1 (the ability to interact with the X protein and attract it to the initiation complex) results in and inhibits the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="175">
                    <text>The C-terminal-deletion mutant of hnRNP A1 that may lose A1 (the ability to interact with the X protein and attract it to the initiation complex) results in and inhibits the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="176">
                    <text>The C-terminal-deletion mutant of hnRNP A1 which has a high probability of losing A1 (the ability to interact with the X protein and to lead it to the initiation complex) results in and inhibits the transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="177">
                    <text>The C-terminal-deletion mutation of hnRNP A1 has the ability to lose A1 (the ability to interact with the X protein and carry it to the initiation complex), resulting in transcription inhibition and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="178">
                    <text>The C-terminal-deletion mutation of hnRNP A1 that may lose A1 (the ability to interact with the X protein and attract it to the initiation complex) results in and inhibits transcription and replication of MHV RNA.</text>
                    <arg n="0">The C-terminal-deletion mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="179">
                    <text>The mice can not lose weight during treatment.</text>
                    <arg n="0">The mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="180">
                    <text>The mice do no has the ability to lose weight during treatment.</text>
                    <arg n="0">The mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">no</arg>
                </example>
                <example src="EGRAM" no="181">
                    <text>The mice do not has a high probability of losing weight during treatment.</text>
                    <arg n="0">The mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="182">
                    <text>The mice may have lost weight during treatment.</text>
                    <arg n="0">The mice</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                </example>
                <example src="EGRAM" no="183">
                    <text>The mouse will lose no weight during treatment.</text>
                    <arg n="0">The mouse</arg>
                    <arg n="1">weight</arg>
                    <arg n="2">during treatment</arg>
                    <arg n="M-NEG">no</arg>
                </example>
                <example src="EGRAM" no="184">
                    <text>The no known plastic species can completely lose the its prokaryoto organelle genome, but all exhibit considerable reduction and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no known plastic species</arg>
                    <arg n="1">its prokaryoto organelle genome</arg>
                </example>
                <example src="EGRAM" no="185">
                    <text>The no known plastic species can completely lost the its prokaryoto organelle genome, but all exhibit considerable reduction and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no known plastic species</arg>
                    <arg n="1">its prokaryoto organelle genome</arg>
                </example>
                <example src="EGRAM" no="186">
                    <text>The no known plastic species will completely lose the its prokaryoto organelle genome, but all exhibit considerable reduction and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no known plastic species</arg>
                    <arg n="1">its prokaryoto organelle genome</arg>
                </example>
                <example src="EGRAM" no="187">
                    <text>The no known plastic species will completely lost the its prokaryoto organelle genome, but all exhibit considerable reduction and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no known plastic species</arg>
                    <arg n="1">its prokaryoto organelle genome</arg>
                </example>
                <example src="EGRAM" no="188">
                    <text>The no known species of plastic has the ability to completely lose the its prokaryoto-like genome, but all exhibit considerable genome reduction and core dependence to fulfill the plastic functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no known species of plastic</arg>
                    <arg n="1">its prokaryoto-like genome</arg>
                </example>
                <example src="EGRAM" no="189">
                    <text>The no prokaryotic organelle genome has been completely lost in any known plastid, but all show a considerable reduction in the genome and core dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plastid</arg>
                    <arg n="1">no prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="190">
                    <text>The no prokaryotic organelle genome has the ability to be completely lost in any known plastid, but all exhibit a considerable reduction in the genome and core dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plastid</arg>
                    <arg n="1">no prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="191">
                    <text>The no prokaryotic organelle genome was completely lost in any known plastid, but all show a considerable reduction of the genome and core dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plastid</arg>
                    <arg n="1">no prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="192">
                    <text>The no prokaryotic organelle genome will be completely lost in any known plastid, but all show a considerable reduction in the genome and core dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plastid</arg>
                    <arg n="1">no prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="193">
                    <text>The without genomes of organelles similar to prokaryotes can be lost completely to any known sign, but all show a considerable reduction in the capsule and the dependence of the nucleus to fulfill the functions of padid (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known sign</arg>
                    <arg n="1">without genomes of organelles similar to prokaryotes</arg>
                </example>
                <example src="EGRAM" no="194">
                    <text>The without genomes of organelles similar to prokaryotes is completely lost in any known sign, but all show a considerable reduction in the capsule and the dependence of the nucleus to fulfill the functions of padid (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known sign</arg>
                    <arg n="1">without genomes of organelles similar to prokaryotes</arg>
                </example>
                <example src="EGRAM" no="195">
                    <text>The without genomes of organelles similar to prokaryotes was completely lost to any known sign, but they all show a considerable reduction in the capsule and the dependence of the nucleus to fulfill the functions of padid (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known sign</arg>
                    <arg n="1">without genomes of organelles similar to prokaryotes</arg>
                </example>
                <example src="EGRAM" no="196">
                    <text>These interactions are able to lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="197">
                    <text>These interactions are lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="198">
                    <text>These interactions has the ability to lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="199">
                    <text>These interactions have a high probability of loss of with separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing lost the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="200">
                    <text>These interactions may be lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="201">
                    <text>These interactions may probably be lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="202">
                    <text>These interactions was lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="203">
                    <text>These interactions were able to lost with a separation of the binding sites of }3 ap DNA, as may occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 ap DNA</arg>
                </example>
                <example src="EGRAM" no="204">
                    <text>These interactions were lost as loss of with separation of the binding sites of }3 bp DNA, as may occur for natural SRE sequences, while a minor spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="205">
                    <text>These interactions were lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing would inhibit the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="206">
                    <text>These interactions will be lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="207">
                    <text>These interactions will likely lost with a separation of the binding sites of the DNA of }3 ap , as may occur for natural SRE sequences, while a smaller spacing inhibited the simultaneous binding of both proteins.</text>
                    <arg n="1">These interactions</arg>
                    <arg n="2">with a separation of the binding sites of the DNA of }3 ap</arg>
                </example>
                <example src="EGRAM" no="208">
                    <text>This study investigated whether informing obese individuals that se are capable of losing moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="0">se</arg>
                    <arg n="M-ADV">moderate weight</arg>
                </example>
                <example src="EGRAM" no="209">
                    <text>This study investigated whether obese individuals are likely to losing only ludic weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">ludic weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="210">
                    <text>This study investigated whether obese individuals are likely to losing only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="211">
                    <text>This study investigated whether obese individuals could be able to lose only ludic weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">ludic weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="212">
                    <text>This study investigated whether obese individuals could be informed that A0 (may lose only very weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">very weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="213">
                    <text>This study investigated whether obese individuals could lose only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="214">
                    <text>This study investigated whether obese individuals could lose only nomadic weight quantities would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="0">nomadic weight quantities</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="215">
                    <text>This study investigated whether obese individuals were able to lose only nomadic weight quantity would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">nomadic weight quantity</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="216">
                    <text>This study investigated whether obese individuals would be able to lose only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="217">
                    <text>This study investigated whether obese individuals would be able to lose only modest weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">modest weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="218">
                    <text>This study investigated whether obese individuals would be informed that A0 would lose only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="219">
                    <text>This study investigated whether obese individuals would be informed that scheme loses only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="0">scheme</arg>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="220">
                    <text>This study investigated whether the information of Obese individuals that A0 lost moderate weight only A1 would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="M-ADV">moderate weight only</arg>
                </example>
                <example src="EGRAM" no="221">
                    <text>This study investigated whether the information of Obese individuals that A0 lost only weight module would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">weight module</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="222">
                    <text>This study investigated whether the information of Obese individuals that A0 might lose only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="223">
                    <text>This study investigated whether the information of obese individuals that A0 may lose only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="224">
                    <text>This study investigated whether the information of obese individuals that they could probably lose only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="0">they</arg>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="225">
                    <text>This study investigated whether the information of obese individuals that they may probably lose only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="0">they</arg>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="226">
                    <text>This study investigated whether to inform obese individuals that A0 would probably lose only nomadic weight quantities would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="1">nomadic weight quantities</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="227">
                    <text>This study investigated whether to inform obese individuals that them may likely lose only modic weight quantities would lead them to adopt more realistic weight loss expectations.</text>
                    <arg n="0">them</arg>
                    <arg n="1">modic weight quantities</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="228">
                    <text>This study investigated whether to inform obese individuals that them may lose VAD-M (only) nomadic weight quantities would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="0">them</arg>
                    <arg n="1">nomadic weight quantities</arg>
                </example>
                <example src="EGRAM" no="229">
                    <text>This study investigated whether to inform obese individuals that them would likely lose only modious weight quantities would lead them to adopt more realistic weight loss expectations.</text>
                    <arg n="0">them</arg>
                    <arg n="1">modious weight quantities</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="230">
                    <text>This study investigated whether to inform obese individuals that them would lose only nomadic weight quantities would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="0">them</arg>
                    <arg n="1">nomadic weight quantities</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="231">
                    <text>This study investigated whether to inform obese individuals that they are observed to lose only modic weight quantities would lead them to adopt more realistic weight loss expectations.</text>
                    <arg n="0">they</arg>
                    <arg n="1">modic weight quantities</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="232">
                    <text>This study investigated whether to inform obese individuals that they have the ability to lose only moderate weight would lead them to adopt more realistic expectations of weight loss.</text>
                    <arg n="0">they</arg>
                    <arg n="1">moderate weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="233">
                    <text>This study investigated whether to inform obese individuals that they may lose only too much weight would lead them to adopt more realistic weight loss expectations.</text>
                    <arg n="0">they</arg>
                    <arg n="1">too much weight</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="234">
                    <text>To this end, we caused aggregation chimes between Lc/+ mice to losing all A1 cells (purkinje) postnatally, and +/+ control mice.</text>
                    <arg n="0">aggregation chimes between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="235">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which are able to lose all A1 cells (purkinje) postnatally, and control mice +/+.</text>
                </example>
                <example src="EGRAM" no="236">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which could lose all A1 cells (purkinje) postnatally, and +/+ control mice.</text>
                </example>
                <example src="EGRAM" no="237">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which could probably lose all A1 cells (purkinje) postnatally, and +/+ control mice.</text>
                </example>
                <example src="EGRAM" no="238">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which have a high probability of losing all A1 cells (purkinje) postnatally, and +/+ control mice.</text>
                </example>
                <example src="EGRAM" no="239">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which may lose all A1 cells (purkinje) postnatally, and +/+ control mice.</text>
                </example>
                <example src="EGRAM" no="240">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which may lose all A1 cells (purkinje) postnatally, and control mice +/+.</text>
                </example>
                <example src="EGRAM" no="241">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which will lose all A1 cells (purkinje) postnatally, and control mice +/+.</text>
                </example>
                <example src="EGRAM" no="242">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which will probably lose all A1 cells (purkinje) postnatally, and +/+ control mice.</text>
                </example>
                <example src="EGRAM" no="243">
                    <text>To this end, we made a0 (accessing chimes between Lc/+ mice), which would lose all A1 cells (purkinje) postnatally, and control mice +/+.</text>
                </example>
                <example src="EGRAM" no="244">
                    <text>To this end, we made a0 (accessive clusters between Lc/+ mice), which have the ability to lose all A1 cells (purkinje) postnatally, and +/+ control mice.</text>
                </example>
                <example src="EGRAM" no="245">
                    <text>To this end, we made a0 (aggregational circles between Lc/+ mice), which are observed to lose all A1 cells (purkinje) postnatally, and control mice +/+.</text>
                </example>
                <example src="EGRAM" no="246">
                    <text>To this end, we made a0 (aggregational circles between Lc/+ mice), which may lose all A1 cells (purkinje) postnatally, and control mice +/+.</text>
                </example>
                <example src="EGRAM" no="247">
                    <text>a Sph I division site within exon 3 was lost in a new variant of transtiretin which has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a Sph I division site within exon 3</arg>
                </example>
                <example src="EGRAM" no="248">
                    <text>a Sph I segmentation site within exon 3 can be lost in a new variant of transtiretin that has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a Sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="249">
                    <text>a Sph I segmentation site within exon 3 has been lost in a new variant of transtiretin which has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a Sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="250">
                    <text>a Sph I segmentation site within exon 3 is lost in a new transthyretin variant that has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a Sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="251">
                    <text>a Sph I segmentation site within exon 3 will be lost in a new transthyretin variant that has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a Sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="252">
                    <text>a new transthyretin variant has been characterized to lose a segmentation site Sph I within exon 3.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a segmentation site Sph I within exon 3</arg>
                </example>
                <example src="EGRAM" no="253">
                    <text>a new transthyretin variant that has the ability to lose a Sph I segmentation site within exon 3 has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a Sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="254">
                    <text>a new transthyretin variant that loses a Sph I cleavage site within exon 3 has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="EGRAM" no="255">
                    <text>a new transthyretin variant that losing a Sph I segmentation site within exon 3 has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a Sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="256">
                    <text>a new transthyretin variant that may lose a Sph I cleavage site within exon 3 has been characterised.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a Sph I cleavage site within exon 3</arg>
                </example>
                <example src="EGRAM" no="257">
                    <text>a new transthyretin variant that was observed to lose a Sph I segmentation site within exon 3 was characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a Sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="258">
                    <text>a new variant of transtiretin that has been observed to lose a site of Sph I segmentation within exon 3 has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a site of Sph I segmentation within exon 3</arg>
                </example>
                <example src="EGRAM" no="259">
                    <text>a new variant of transtiretin that has the ability to lose a site of Sph I segmentation within exon 3 has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a site of Sph I segmentation within exon 3</arg>
                </example>
                <example src="EGRAM" no="260">
                    <text>a new variant of transtiretin that losing a site of Sph I segmentation within exon 3 has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a site of Sph I segmentation within exon 3</arg>
                </example>
                <example src="EGRAM" no="261">
                    <text>a new variant of transtiretin that may lose a site of Sph I segmentation within exon 3 has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a site of Sph I segmentation within exon 3</arg>
                </example>
                <example src="EGRAM" no="262">
                    <text>a place of segmentation Sph I within exon 3 is observed to be lost in a new variant of transtiretin that has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a place of segmentation Sph I within exon 3</arg>
                </example>
                <example src="EGRAM" no="263">
                    <text>a site of Sph I cleavage within exon 3 is able to be lost in a new transthyretin variant that has been characterised.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a site of Sph I cleavage within exon 3</arg>
                </example>
                <example src="EGRAM" no="264">
                    <text>a site of Sph I cleavage within exon 3 is lost in a new transthyretin variant that has been characterised.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a site of Sph I cleavage within exon 3</arg>
                </example>
                <example src="EGRAM" no="265">
                    <text>a site of Sph I cleavage within exon 3 may be lost in a new transthyretin variant that has been characterised.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a site of Sph I cleavage within exon 3</arg>
                </example>
                <example src="EGRAM" no="266">
                    <text>a site of Sph I cleavage within exon 3 was lost in a new transthyretin variant that was characterised.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a site of Sph I cleavage within exon 3</arg>
                </example>
                <example src="EGRAM" no="267">
                    <text>a site of Sph I cleavage within exon 3 will be lost in a new transthyretin variant that has been characterised.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a site of Sph I cleavage within exon 3</arg>
                </example>
                <example src="EGRAM" no="268">
                    <text>a site of Sph I segmentation within exon 3 may be lost in a new transthyretin variant that has been characterized.</text>
                    <arg n="0">a new transthyretin variant</arg>
                    <arg n="1">a site of Sph I segmentation within exon 3</arg>
                </example>
                <example src="EGRAM" no="269">
                    <text>a sph I segmentation site within exon 3 is observed to be lost in a new variant of transtiretin that has been characterized.</text>
                    <arg n="0">a new variant of transtiretin</arg>
                    <arg n="1">a sph I segmentation site within exon 3</arg>
                </example>
                <example src="EGRAM" no="270">
                    <text>all P. aureus A1 cells will be lost in the postnatal period by liquids of aggregation between Lc/+ mice.</text>
                    <arg n="0">liquids of aggregation between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="271">
                    <text>all P. aureus A1 cells will probably be lost in the postnatal period by likely aggregation clusters between Lc/+ mice.</text>
                    <arg n="0">likely aggregation clusters between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="272">
                    <text>all P. aureus A1 cells would probably be lost in the postnatal period by chimera of aggregation between Lc/+ mice.</text>
                    <arg n="0">chimera of aggregation between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="273">
                    <text>all P. aureus cells are able to be lost in the postnatal period by aggregation keratos between Lc/+ mice.</text>
                    <arg n="0">aggregation keratos between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="274">
                    <text>all P. aureus cells are lost in the postnatal period by chimera of aggregation between Lc/+ mice.</text>
                    <arg n="0">chimera of aggregation between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="275">
                    <text>all P. aureus cells can be lost in the postnatal period by assembly clusters between Lc/+ mice.</text>
                    <arg n="0">assembly clusters between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="276">
                    <text>all P. aureus cells have a high probability of being lost in the postnatal period by assembly clusters between Lc/+ mice.</text>
                    <arg n="0">assembly clusters between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="277">
                    <text>all P. aureus cells were lost as postnatal loss by assembly quantities of Lc/+ mice.</text>
                    <arg n="0">assembly quantities of Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="278">
                    <text>all P. aureus cells were lost in the postnatal period by chimera of aggregation between Lc/+ mice.</text>
                    <arg n="0">chimera of aggregation between Lc/+ mice</arg>
                </example>
                <example src="EGRAM" no="279">
                    <text>hnRNP A1 C-terminal mutant is able to lose A1 (the ability to interact with the X protein and to introduce it into the initiation complex), resulting in inhibition of RNA transcription and replication.</text>
                    <arg n="0">hnRNP A1 C-terminal mutant</arg>
                </example>
                <example src="EGRAM" no="280">
                    <text>hnRNP A1 C-terminal mutant may lose A1 (the ability to interact with the X protein and to introduce it into the initiation complex), resulting in inhibition of RNA transcription and replication.</text>
                    <arg n="0">hnRNP A1 C-terminal mutant</arg>
                </example>
                <example src="EGRAM" no="281">
                    <text>hnRNP A1 C-terminal mutant may lose A1 (the interaction capacity with the X protein and to transport it to the initiation complex), resulting in inhibition of transcription and replication of MHV RNA.</text>
                    <arg n="0">hnRNP A1 C-terminal mutant</arg>
                </example>
                <example src="EGRAM" no="282">
                    <text>no genome of prokaryote-like organelles is able to be completely lost in any known plaside, but all show considerable reduction of the plaside and dependence of the core to fulfill the plaside functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plaside</arg>
                    <arg n="1">no genome of prokaryote-like organelles</arg>
                </example>
                <example src="EGRAM" no="283">
                    <text>no genome of prokaryotic organelles is completely lost in any known plaside, but all have considerable genome reduction and dependence on the core to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plaside</arg>
                    <arg n="1">no genome of prokaryotic organelles</arg>
                </example>
                <example src="EGRAM" no="284">
                    <text>no plastid is known can completely lose its prokaryotic organelle genome, but they all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="285">
                    <text>no plastid is known has completely lost its prokaryotic organelle genome, but all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="286">
                    <text>no plastid is known will completely lose its prokaryotic organelle genome, but they all show a considerable reduction in the genome and core dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">no plastid is known</arg>
                    <arg n="1">its prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="287">
                    <text>no prokaryotic organelle genome can be completely lost in any known plastid, but they all show a considerable reduction in the genome and dependence on the nucleus to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plastid</arg>
                    <arg n="1">no prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="288">
                    <text>not known about plastids is able to completely lose prokaryotic organelle gene, but all show a considerable reduction in the genome and the nucleus dependence to fulfill the functions of plastids (Martin and Hrrmann, 1998).</text>
                    <arg n="0">not known about plastids</arg>
                    <arg n="1">prokaryotic organelle gene</arg>
                </example>
                <example src="EGRAM" no="289">
                    <text>six interactions was observed to lost with a separation of the binding sites of }3 bp DNA, as may occur in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">six interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="290">
                    <text>the C-terminal mutant of hnRNP A1 that lost A1 (the ability to interact with the X protein and transport it to the initiation complex) results in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="291">
                    <text>the C-terminal mutation of hnRNP A1 has been losing A1 (the ability to interact with the X protein and transport it to the initiation complex), resulting in inhibition of transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="292">
                    <text>the C-terminal mutation of hnRNP A1 lost A1 (the ability to interact with the X protein and transport it to the initiation complex), resulting in inhibition of transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="293">
                    <text>the C-terminal mutation of hnRNP A1 may have lost A1 (the ability to interact with the X protein and transport it to the initiation complex), resulting in inhibition of transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="294">
                    <text>the C-terminal mutation of hnRNP A1 that lost A1 (the ability to interact with the X protein and to carry it to the initiation complex) results in inhibition of the transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="295">
                    <text>the C-terminal mutation of hnRNP A1 will lose A1 (the interaction capacity with the X protein and to transport it to the initiation complex), resulting in inhibition of transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="296">
                    <text>the C-terminal mutation of hnRNP A1 will probably lose A1 (the interaction capacity with the X protein and to transport it to the initiation complex), resulting in inhibition of transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="297">
                    <text>the C-terminal-deletion mutant of hnRNP A1 has a high probability of losing A1 (the ability to interact with the X protein and carry it to the initiation complex), resulting in transcription inhibition and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="298">
                    <text>the C-terminal-deletion mutant of hnRNP A1 has a high probability of losing A1 (the ability to interact with the X protein and to carry it into the initiation complex) results in inhibition of transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="299">
                    <text>the C-terminal-deletion mutant of hnRNP A1 may lose A1 (the ability to interact with the X protein and carry it to the initiation complex), resulting in transcription inhibition and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="300">
                    <text>the C-terminal-deletion mutant of hnRNP A1 that has lost A1 (the ability to interact with the X protein and carry it to the initiation complex) results in transcription inhibition and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="301">
                    <text>the C-terminal-deletion mutant of hnRNP A1 that losing A1 (the ability to interact with the X protein and carry it to the initiation complex) results in inhibition of transcription and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal-deletion mutant of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="302">
                    <text>the C-terminal-deletion mutation of hnRNP A1 that may lose A1 (the ability to interact with the X protein and carry it to the initiation complex) results in transcription inhibition and replication of MHV RNA.</text>
                    <arg n="0">the C-terminal-deletion mutation of hnRNP A1</arg>
                </example>
                <example src="EGRAM" no="303">
                    <text>the ability to interact with the X protein and drive it to the initiation complex can be lost in the C-terminal-deletion mutant of hnRNP A1.</text>
                    <arg n="0">the C-terminal-deletion mutant of hnRNP A1</arg>
                    <arg n="1">the ability to interact with the X protein and drive it to the initiation complex</arg>
                </example>
                <example src="EGRAM" no="304">
                    <text>the ability to interact with the X protein and to lead it to the initiation complex may be lost in the C-terminal-deletion mutant of hnRNP A1.</text>
                    <arg n="0">the C-terminal-deletion mutant of hnRNP A1</arg>
                    <arg n="1">the ability to interact with the X protein and to lead it to the initiation complex</arg>
                </example>
                <example src="EGRAM" no="305">
                    <text>the hnRNP A1 mutation C-terminal-deletion is able to lose A1 (the ability to interact with the X protein and carry it to the initiation complex), resulting in transcription inhibition and replication of MHV RNA.</text>
                    <arg n="0">the hnRNP A1 mutation C-terminal-deletion</arg>
                </example>
                <example src="EGRAM" no="306">
                    <text>these interactions has a high probability of loss of with separation of the binding sites of }3 bp DNA, as may lost in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="307">
                    <text>these interactions has the ability to lost with a separation of the binding sites of }3 bp DNA, as may occur in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="308">
                    <text>these interactions is likely to lost with a separation of the DNA binding sites of }3 ap, as can occur in natural SRE sequences, while smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the DNA binding sites of }3 ap</arg>
                </example>
                <example src="EGRAM" no="309">
                    <text>these interactions lost with a separation of the binding sites of }3 bp DNA, as may occur in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="310">
                    <text>these interactions may be lost to with a separation of the binding sites of }3 bp DNA, as may occur in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="311">
                    <text>these interactions may probably lost with a separation of the binding sites of }3 bp DNA, as may occur in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="312">
                    <text>these interactions was able to lost with a separation of the binding sites of }3 bp DNA, as may occur in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="313">
                    <text>these interactions was observed to lost with a separation of the DNA-binding sites of }3 bp, as can occur in natural SRE sequences, while smaller spacing inhibits simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the DNA-binding sites of }3 bp</arg>
                </example>
                <example src="EGRAM" no="314">
                    <text>these interactions will likely lost with a separation of the binding sites of }3 bp DNA, as may occur in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="315">
                    <text>these interactions will lost with a separation of the binding sites of }3 bp DNA, as may occur in natural SRE sequences, while a smaller spacing inhibits the simultaneous binding of both proteins.</text>
                    <arg n="1">these interactions</arg>
                    <arg n="2">with a separation of the binding sites of }3 bp DNA</arg>
                </example>
                <example src="EGRAM" no="316">
                    <text>without prokaryotic organelle genome has the ability to be completely lost in any known plaside, but all have a considerable reduction in genome and nucleus dependence to fulfill the plaside functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plaside</arg>
                    <arg n="1">without prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="317">
                    <text>without prokaryotic organelle genome is able to be completely lost in any known plaside, but all have a considerable reduction in genome and nucleus dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plaside</arg>
                    <arg n="1">without prokaryotic organelle genome</arg>
                </example>
                <example src="EGRAM" no="318">
                    <text>without prokaryotic organelle genome will be completely lost in any known plaside, but all show a considerable reduction in genome and nucleus dependence to fulfill the plastid functions (Martin and Hrrmann, 1998).</text>
                    <arg n="0">any known plaside</arg>
                    <arg n="1">without prokaryotic organelle genome</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
